Anika Therapeutics ANIK Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| Commercial Channel | $12.58M+11.7% | $13.3M+21.7% | $11.97M+22.2% | $11.88M+0.4% | $11.26M+17.6% | |
| OEM Channel | $17.04M+14.3% | $17.31M-12.0% | $15.84M-19.8% | $16.34M-13.5% | $14.91M-23.3% | |
| Revenue by Geography | ||||||
| Europe | $6.67M+15.0% | $6M+38.5% | $5.67M+18.2% | $4.75M-16.8% | $5.8M+27.0% | |
| Other Location | $4.41M+10.2% | $6.29M+29.1% | $4.7M+12.6% | $5.54M+12.6% | $4.01M-1.9% | |
| US | $18.53M+13.0% | $18.37M-14.2% | $17.45M-15.3% | $17.92M-10.8% | $16.4M-19.6% | |
| Percentage Of Net Revenue by Geography | ||||||
| Europe | 22%0.0pp | —— | 20%+4.0pp | 17%-2.0pp | 22%+6.0pp | |
| Other Location | 15%0.0pp | 1%— | 17%+3.0pp | 20%+4.0pp | 15%+1.0pp | |
| US | 63%0.0pp | —— | 63%-7.0pp | 63%-2.0pp | 63%-7.0pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Anika Therapeutics break its business down?
- Anika Therapeutics (ANIK) reports revenue by product across 2 parts — Commercial Channel and OEM Channel. Each is extracted from the segment footnotes and tracked over time.
- Where does Anika Therapeutics's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Anika Therapeutics's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
